Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

transcreation

- PMLiVE

11 London and B Corp

Three years ago, 11 London became the first UK health agency to gain B-Corp accreditation. CEO and Co-Founder, Matt Hunt reports back on life in the B-List...

11 London

Beyond The Hype: What AI Really Means For Health Communications

While AI is reshaping frontline healthcare at pace—spotting cancers, triaging patients, and summarising records—its uptake in health communications remains tentative. Agencies are experimenting behind the scenes, but real integration is...

Fox&Cat

- PMLiVE

Novartis to invest $23bn into US-based infrastructure over next five years

The commitment will allow the company to produce 100% of its key medicines end-to-end in the US

- PMLiVE

Johnson & Johnson’s subcutaneous Rybrevant granted EC approval to treat NSCLC

It is hoped that the formulation will improve the treatment experience for patients

Bayer symbol

Bayer’s Vitrakvi receives full FDA approval for NTRK gene fusion-positive tumours

The US regulator first approved the TRK inhibitor in 2018 under its accelerated approval pathway

ISPOR partner seal

Genesis Research Group announces inaugural membership of ISPOR Corporate Partnership Program

Genesis Research Group, a pioneer of tech-enabled real-world evidence (RWE), health economics and outcomes research (HEOR), and market access services, today announces it has joined selected organizations as an inaugural...

Genesis Research Group

- PMLiVE

Map the Patient Journey Virtually – Engaging Your Advisors Creatively

Improve patient experiences! Learn how to co-create patient journey maps with your advisors virtually, identify healthcare gaps, and streamline care pathways.

Impetus Digital

Woman working at laptop

How is generative AI transforming clinical trials?

Discover how generative AI is revolutionising clinical trials, from enhancing patient recruitment to improving data analysis.

Cuttsy + Cuttsy

- PMLiVE

AstraZeneca/Daiichi Sankyo’s Datroway approved by EC to treat breast cancer

Approximately 557,000 people are diagnosed with breast cancer every year in Europe

- PMLiVE

Sanofi’s tolebrutinib shown to delay MS disability progression in phase 3 study

The BTK inhibitor has been granted FDA priority review to treat the neurodegenerative disease

- PMLiVE

Compass Therapeutics’ tovecimig shows promise in phase 2/3 biliary tract cancer study

Around 23,000 cases of the aggressive cancer are diagnosed in the US every year

- PMLiVE

BMS granted FDA approval for immunotherapy combination in colorectal cancer

More than 154,000 cases of the disease are expected to be diagnosed in the US this year

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links